Withum Woburn Team Member Advances to Partner with New Partner Class

Jul 07, 2022

Posted by WithumSmith+Brown, PC

Scott A. Kaplan A “Go To” Lawyer, Says Massachusetts Lawyers Weekly

Jul 07, 2022

Accord BioPharma and EVERSANA Announce Partnership to Support the Launch of CAMCEVI® for the Treatment of Advanced Prostate Cancer in Adults in the U.S.

Jun 29, 2022

Posted by EVERSANA

Batavia Biosciences enters the commercial manufacturing business

Jun 28, 2022

Digital Health Industry Take Note: New HIPAA Comment Opportunity and Guidance Addresses Growing Risk of Cybersecurity Attacks

Jun 21, 2022

MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022

Jun 16, 2022

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

Jun 16, 2022

Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis

Jun 15, 2022

Posted by Sumitomo Pharma Oncology, Inc.